Nomination Background: Alpha-Thujone
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Molecular Regulation of Plant Monoterpene Biosynthesis in Relation to Fragrance
Molecular Regulation of Plant Monoterpene Biosynthesis In Relation To Fragrance Mazen K. El Tamer Promotor: Prof. Dr. A.G.J Voragen, hoogleraar in de Levensmiddelenchemie, Wageningen Universiteit Co-promotoren: Dr. ir. H.J Bouwmeester, senior onderzoeker, Business Unit Celcybernetica, Plant Research International Dr. ir. J.P Roozen, departement Agrotechnologie en Voedingswetenschappen, Wageningen Universiteit Promotiecommissie: Dr. M.C.R Franssen, Wageningen Universiteit Prof. Dr. J.H.A Kroeze, Wageningen Universiteit Prof. Dr. A.J van Tunen, Swammerdam Institute for Life Sciences, Universiteit van Amsterdam. Prof. Dr. R.G.F Visser, Wageningen Universiteit Mazen K. El Tamer Molecular Regulation Of Plant Monoterpene Biosynthesis In Relation To Fragrance Proefschrift ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. dr. ir. L. Speelman, in het openbaar te verdedigen op woensdag 27 november 2002 des namiddags te vier uur in de Aula Mazen K. El Tamer Molecular Regulation Of Plant Monoterpene Biosynthesis In Relation To Fragrance Proefschrift Wageningen Universiteit ISBN 90-5808-752-2 Cover and Invitation Design: Zeina K. El Tamer This thesis is dedicated to my Family & Friends Contents Abbreviations Chapter 1 General introduction and scope of the thesis 1 Chapter 2 Monoterpene biosynthesis in lemon (Citrus limon) cDNA isolation 21 and functional analysis of four monoterpene synthases Chapter 3 Domain swapping of Citrus limon monoterpene synthases: Impact 57 on enzymatic activity and -
Drying Effects on Chemical Composition and Antioxidant Activity of Lippia Thymoides Essential Oil, a Natural Source of Thymol
molecules Article Drying Effects on Chemical Composition and Antioxidant Activity of Lippia thymoides Essential Oil, a Natural Source of Thymol Lidiane Diniz do Nascimento 1,2,* , Sebastião Gomes Silva 3 ,Márcia Moraes Cascaes 4, Kauê Santana da Costa 5,* , Pablo Luis Baia Figueiredo 6 , Cristiane Maria Leal Costa 7, Eloisa Helena de Aguiar Andrade 2,4 and Lênio José Guerreiro de Faria 1,7 1 Programa de Pós-Graduação em Engenharia de Recursos Naturais da Amazônia, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 2 Coordenação de Botânica, Museu Paraense Emílio Goeldi, Belém 66077-830, Pará, Brazil; [email protected] 3 Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 4 Programa de Pós-Graduação em Química, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 5 Faculdade de Biotecnologia, Instituto de Biodiversidade, Universidade Federal do Oeste do Pará, Santarém 68035-110, Pará, Brazil 6 Departamento de Ciências Naturais, Universidade do Estado do Pará, Belém 66050-540, Pará, Brazil; pablo.fi[email protected] 7 Programa de Pós-Graduação em Engenharia Química, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] Citation: Nascimento, L.D.d.; Silva, * Correspondence: [email protected] (L.D.d.N.); [email protected] (K.S.d.C.); S.G.; Cascaes, M.M.; Costa, K.S.d.; Tel.: +55-91-3217-6086 (L.D.d.N.); +55-93-2101-6771 (K.S.d.C.) Figueiredo, P.L.B.; Costa, C.M.L.; Andrade, E.H.d.A.; de Faria, L.J.G. -
Retention Indices for Frequently Reported Compounds of Plant Essential Oils
Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5. -
Picrotoxin-Like Channel Blockers of GABAA Receptors
COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1). -
NTP Annual Report 2012
National Toxicology Program U.S. Department of Health and Human Services Annual Report 2012 National Toxicology Program ANNUAL REPORT for Fiscal Year 2012 National Institute of Environmental Health Sciences National Institutes of Health National Center for Toxicological Research Food and Drug Administration National Institute for Occupational Safety and Health Centers for Disease Control and Prevention September 2013 Department of Health and Human Services National Toxicology Program NIH Publication No. 13-5970 Table of Contents Letter from the NIEHS/NTP Director ...................................................................................................... 1 1. National Toxicology Program: Mission And Goals ....................................................................... 3 A. Organizational Structure and Oversight ...................................................................................... 4 B. Training Programs ....................................................................................................................... 6 C. Advisory Boards and Committees ............................................................................................... 6 i. NTP Executive Committee .................................................................................................6 ii. NTP Board of Scientific Counselors ...................................................................................7 iii. Scientific Advisory Committee on Alternative Toxicological Methods .................................9 -
Erowid Extracts — Number 13 / November 2007 Erowid Extracts Table of Contents Number 13, November 2007
Erowid® Extracts D OCUMENTING THE C OMPLEX R ELATIONSHIP B ETWEEN H UMANS AN D P SYCHOACTIVES November 2007 Number 13 “The problem to be faced is: how to combine loyalty to one’s own tradition with reverence for different traditions.” — Abraham J. Heschel The Absinthe Enigma • Wormwood and Thujone • P. viridis vs. M. tenuiflora Varieties of Nicotine Experience • Khat Legal Challenges LETTERS & FEEDBACK Hi there Erowid staff, First of all, thank you for such Awesome website! A more thoughtfully a wonderful site. I’m not a serious compiled compendium of information I’m just writing to say how much I recreational user, but having some on the topic of psychoactives does appreciate your website. My father chronic pain issues, I tend to experiment not exist—at least not for the public showed it to me several years ago a little to find ways to alleviate the at large. Bravo. and it’s been fun to watch it grow pain (aside from standard Rx’s from in quality and content over the — ANOnymOus doctors). […] years. My dad adjunctly teaches a Letter to Erowid psychopharmacology class in town and Keep up the good work. Although always lists Erowid on his syllabus of some might look at Erowid negatively, recommended readings. I’m a college I look at it positively, in the sense that After looking up information on the student and am surprised, once I I’m smart enough to research things antitussive properties of DXM, how start talking to other kids, how many before I try them, and hopefully keep shocked I was to find your website, of them know about the information myself from an early demise. -
Methylcyclopentanone Condensed with Methyl Vinyl Ketone to Give the Dione
In presenting the dissertation as a partial fulfillment of the requirements for an advanced degree from the Georgia Institute of Technology, I agree that the Library of the Institute shall make it available for inspection and circulation in accordance with its regulations governing materials of this type. I agree that permission to copy from, or to publish from, this dissertation may be granted by the professor under whose direction it was written, or, in his absence, by the Dean of the Graduate Division when such copying or publication is solely for scholarly purposes and does not involve potential f inane ia]. gain. It is under stood that any copying from, or publication of, this dis sertation which involves potential financial gain will not be allowed without written permission. 3/17/65 PART I REACTIONS OF ENOLATES DERIVED FROM UNSYMMETRICAL CYCLIC KETONES PART n PHOTOCHEMICAL REARRANGEMENTS OF CROSS CONJUGATED CYCLOHEXADIENONES RELATED TO INDAN A THESIS Presented to The Faculty of the Graduate Division by William Joseph Powers, III In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Chemistry Georgia Institute of Technology May, 1968 PART I REACTIONS OF ENOLATES DERIVED FROM UNSYMMETRICAL CYCLIC KETONES PART II PHOTOCHEMICAL REARRANGEMENTS OF CROSS CONJUGATED CYCLOHEXADIENONES RELATED TO INDAN Approved: Chairman —T, approved by Cha&limn: "JY\ 0*^ 7y 1 ii ACKNOWLEDGMENTS The author is grateful to Professor Drury S. Caine, III for suggesting these problems and for his patience and guidance throughout the course of this research. The author also wishes to thank Professors John R. Dyer and Charles L. -
Assessment Report on Salvia Officinalis L., Folium and Salvia Officinalis L., Aetheroleum Final
20 September 2016 EMA/HMPC/150801/2015 Committee on Herbal Medicinal Products (HMPC) Assessment report on Salvia officinalis L., folium and Salvia officinalis L., aetheroleum Final Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Herbal substance(s) (binomial scientific name of Salvia officinalis L., folium and the plant, including plant part) Salvia officinalis L., aetheroleum Herbal preparation(s) a) Comminuted herbal substance b) Liquid extract (DER 1:1), extraction solvent ethanol 70% V/V c) Dry extract (DER 4-7:1), extraction solvent water d) Liquid extract (DER 1:3.5-5), extraction solvent ethanol 31.5% V/V e) Liquid extract (DER 1:4-5) extraction solvent ethanol 50% V/V f) Liquid extract (DER 1:4-6), extraction solvent liquor wine:ethanol 96% V/V (38.25:61.75 m/m) g) Tincture (ratio of herbal substance to extraction solvent 1:10) extraction solvent ethanol 70% V/V Pharmaceutical form(s) Comminuted herbal substance as herbal tea for oral use. Comminuted herbal substance for infusion preparation for oromucosal or cutaneous use. Herbal preparations in solid or liquid dosage forms for oral use. Herbal preparations in liquid or semi-solid dosage forms for cutaneous use or for oromucosal use. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. -
Plant-Based Medicines for Anxiety Disorders, Part 2: a Review of Clinical Studies with Supporting Preclinical Evidence
CNS Drugs 2013; 24 (5) Review Article Running Header: Plant-Based Anxiolytic Psychopharmacology Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence Jerome Sarris,1,2 Erica McIntyre3 and David A. Camfield2 1 Department of Psychiatry, Faculty of Medicine, University of Melbourne, Richmond, VIC, Australia 2 The Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, VIC, Australia 3 School of Psychology, Charles Sturt University, Wagga Wagga, NSW, Australia Correspondence: Jerome Sarris, Department of Psychiatry and The Melbourne Clinic, University of Melbourne, 2 Salisbury Street, Richmond, VIC 3121, Australia. Email: [email protected], Acknowledgements Dr Jerome Sarris is funded by an Australian National Health & Medical Research Council fellowship (NHMRC funding ID 628875), in a strategic partnership with The University of Melbourne, The Centre for Human Psychopharmacology at the Swinburne University of Technology. Jerome Sarris, Erica McIntyre and David A. Camfield have no conflicts of interest that are directly relevant to the content of this article. 1 Abstract Research in the area of herbal psychopharmacology has revealed a variety of promising medicines that may provide benefit in the treatment of general anxiety and specific anxiety disorders. However, a comprehensive review of plant-based anxiolytics has been absent to date. Thus, our aim was to provide a comprehensive narrative review of plant-based medicines that have clinical and/or preclinical evidence of anxiolytic activity. We present the article in two parts. In part one, we reviewed herbal medicines for which only preclinical investigations for anxiolytic activity have been performed. In this current article (part two), we review herbal medicines for which there have been both preclinical and clinical investigations for anxiolytic activity. -
The Ayurvedic Pharmacopoeia of India
THE AYURVEDIC PHARMACOPOEIA OF INDIA PART- I VOLUME – V GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF AYUSH Contents | Monographs | Abbreviations | Appendices Legal Notices | General Notices Note: This e-Book contains Computer Database generated Monographs which are reproduced from official publication. The order of contents under the sections of Synonyms, Rasa, Guna, Virya, Vipaka, Karma, Formulations, Therapeutic uses may be shuffled, but the contents are same from the original source. However, in case of doubt, the user is advised to refer the official book. i CONTENTS Legal Notices General Notices MONOGRAPHS Page S.No Plant Name Botanical Name No. (as per book) 1 ËMRA HARIDRË (Rhizome) Curcuma amada Roxb. 1 2 ANISÍNA (Fruit) Pimpinella anisum Linn 3 3 A×KOLAH(Leaf) Alangium salviifolium (Linn.f.) Wang 5 4 ËRAGVËDHA(Stem bark) Cassia fistula Linn 8 5 ËSPHOÙË (Root) Vallaris Solanacea Kuntze 10 6 BASTËNTRÌ(Root) Argyreia nervosa (Burm.f.)Boj. 12 7 BHURJAH (Stem Bark) Betula utilis D.Don 14 8 CAÛÚË (Root) Angelica Archangelica Linn. 16 9 CORAKAH (Root Sock) Angelica glauca Edgw. 18 10 DARBHA (Root) Imperata cylindrica (Linn) Beauv. 21 11 DHANVAYËSAH (Whole Plant) Fagonia cretica Linn. 23 12 DRAVANTÌ(Seed) Jatropha glandulifera Roxb. 26 13 DUGDHIKË (Whole Plant) Euphorbia prostrata W.Ait 28 14 ELAVËLUKAê (Seed) Prunus avium Linn.f. 31 15 GAÛÚÌRA (Root) Coleus forskohlii Briq. 33 16 GAVEDHUKA (Root) Coix lachryma-jobi LInn 35 17 GHOÛÙË (Fruit) Ziziphus xylopyrus Willd. 37 18 GUNDRËH (Rhizome and Fruit) Typha australis -
WO 2018/005935 Al 04 January 2018 (04.01.2018) W !P O PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/005935 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12N 15/52 (2006.01) C12P 5/00 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, C12N 15/79 (2006.01) C12P 7/22 (2006.01) KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY,MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (21) International Application Number: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, PCT/US20 17/040224 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, (22) International Filing Date: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 30 June 2017 (30.06.2017) (84) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (26) Publication Langi English UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (30) Priority Data: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 62/357,618 0 1 July 2016 (01 .07.2016) US EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (71) Applicant: INTERNATIONAL FLAVORS & FRA¬ TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, GRANCES INC. -
Rapid Determination of Total Thujone in Absinthe Using 1H NMR Spectroscopy
Hindawi Publishing Corporation International Journal of Spectroscopy Volume 2011, Article ID 171684, 5 pages doi:10.1155/2011/171684 Research Article Rapid Determination of Total Thujone in Absinthe Using 1H NMR Spectroscopy Yulia B. Monakhova, 1, 2 Thomas Kuballa,1 and Dirk W. Lachenmeier1 1 Chemisches und Veterinaruntersuchungsamt¨ (CVUA) Karlsruhe, Weissenburger Strasse 3, 76187 Karlsruhe, Germany 2 Department of Chemistry, Saratov State University, Astrakhanskaya Street 83, Saratov 410012, Russia Correspondence should be addressed to Dirk W. Lachenmeier, [email protected] Received 31 May 2011; Revised 11 July 2011; Accepted 19 July 2011 Academic Editor: Karol Jackowski Copyright © 2011 Yulia B. Monakhova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 1H NMR spectroscopy is utilized to quantify total thujone (sum of α-andβ-isomers) in absinthe. For sample preparation, a simple dilution with buffer is required. Thujone produces a distinct peak of the CH2 group in the cyclopentanone moiety in the 2.13– 2.11 ppm range. No overlap with other typical constituents such as anethole or fenchone occurs. The detection limit of 0.3 mg/L is adequate to control the EU maximum limit. The relative standard deviation was 6%, and linearity was observed from 1 to 100 mg/L. Applicability was proven by analysis of 69 authentic absinthes. The correlation between NMR and our previous method consisting of liquid-liquid extraction followed by GC/MS was significant (P<0.0001, R = 0.93). The simple and cheap NMR method can be used for rapid screening of absinthes for total thujone content while chromatographic techniques are recommended for more specific (α-andβ-thujone isomers) analysis if required.